Atlas Trials

Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis

Clinical trial NCT02217475 · COMPLETED

Trial details

NCT number
NCT02217475
Sponsor
Tobira Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Nonalcoholic Steatohepatitis
Start date
2014-09-18
Primary completion
2016-06-30
Enrollment
289

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.